As of January 22, 2025, Atara Biotherapeutics (ATRA) has a market cap of $39.685 million USD. According to our data, Atara Biotherapeutics is ranked No.8286 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $39.68 M |
-48.23%
|
Dec 31, 2024 | $76.66 M |
3.78%
|
Dec 29, 2023 | $73.87 M |
-84.36%
|
Dec 30, 2022 | $0.47 B |
-79.19%
|
Dec 31, 2021 | $2.27 B |
-19.71%
|
Dec 31, 2020 | $2.83 B |
19.19%
|
Dec 31, 2019 | $2.37 B |
-52.59%
|
Dec 31, 2018 | $5.00 B |
91.93%
|
Dec 29, 2017 | $2.61 B |
27.46%
|
Dec 30, 2016 | $2.04 B |
-46.23%
|
Dec 31, 2015 | $3.80 B |
-1.27%
|
Dec 31, 2014 | $3.85 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
bluebird bio
BLUE
|
$76.22 M |
0.000 M
|
USA
|
Adaptimmune Therapeutics
ADAP
|
$0.15 B |
0.000 M
|
UK
|
Allogene Therapeutics
ALLO
|
$0.40 B |
0.000 M
|
USA
|
Fate Therapeutics
FATE
|
$0.15 B |
0.000 M
|
USA
|
CRISPR Therapeutics
CRSP
|
$3.77 B |
-0.000 M
|
Switzerland
|
Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
USA
|
Intellia Therapeutics
NTLA
|
$1.12 B |
0.000 M
|
USA
|
Sangamo Therapeutics
SGMO
|
$0.24 B |
-0.000 M
|
USA
|
Cellectis
CLLS
|
$0.16 B |
4.659 M
|
France
|
Iovance Biotherapeutics
IOVA
|
$1.83 B |
-0.000 M
|
USA
|
Precision BioSciences
DTIL
|
$38.13 M |
0.000 M
|
USA
|
Market Cap | = | ATRA Stock Price | * | ATRA Shares Outstanding |
= | $6.89 | * | 5.76 M | |
= | $39.68 M |